New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S2392

Introduced
1/29/24  
Introduced
1/13/26  
Refer
1/29/24  
Refer
1/13/26  
Report Pass
11/13/25  
Refer
11/13/25  

Caption

Authorizes medical cannabis for treatment of sickle cell anemia.

Impact

If enacted, S2392 would affect all signage, placards, license plates, and other markers that identify accessible features such as restrooms and parking spaces. The new requirements would apply to newly installed or replaced signage, but the bill clarifies that existing signs would not need to be replaced unless necessary. This approach mitigates potential funding concerns, as it does not impose additional costs on the state beyond normal expenses incurred for new sign installation.

Summary

S2392 is a legislative proposal in New Jersey that aims to modernize the requirements for signage indicating accessible facilities for individuals with disabilities. The bill proposes replacing the traditional wheelchair symbol with a new logo that features a dynamic character leaning forward, which signifies movement and action. This change is part of a broader trend to promote a more empowering and inclusive representation of accessibility, moving away from symbols that may imply passivity. Additionally, the bill stipulates that the term 'handicapped' be replaced with 'accessible' on relevant signage, aiming for a more respectful language acknowledging the rights of those with disabilities.

Sentiment

The overall sentiment surrounding S2392 is positive, reflecting a growing societal shift toward enhanced disability rights and inclusion. Supporters argue that the updated signage will better communicate accessibility, reduce stigma, and provide a more dignified representation of individuals with disabilities. The sentiment is aligned with an emerging national and international movement advocating for changes in how access is visually represented in public spaces.

Contention

While S2392 has gained support among advocates for disability rights, there may be concerns from some sources regarding the practicality and costs associated with the implementation of the new signage. Nevertheless, the bill is designed to minimize these impacts by ensuring existing signs remain unless replacement is warranted. This balance attempts to address both the need for updated representation and the realities of budget considerations in state-funded programs.

Companion Bills

NJ A913

Replaced by Authorizes medical cannabis for treatment of sickle cell anemia.

NJ A4944

Carry Over Authorizes medical cannabis for treatment of sickle cell anemia.

NJ S3394

Carry Over Authorizes medical cannabis for treatment of sickle cell anemia.

NJ S822

Carry Over Requires State agencies to review operations and to implement use of Internet to conduct public business when cost savings may be realized, with certain exceptions.

NJ A265

Carry Over Establishes "Local Governmental Process Activities Disclosure Act;" expands lobbying disclosure requirements to local level.

Previously Filed As

NJ S2392

Revises requirements for signage indicating accessible facilities for people with disabilities.

NJ HB4934

VEH-SICKLE CELL ANEMIA DECAL

NJ S1758

Authorizes home cultivation of medical cannabis.

NJ A1674

Authorizes home cultivation of medical cannabis.

NJ S1543

Authorizes "100 percent Disabled Veteran" license plates for qualified veterans; entitles holders to handicapped parking privileges.

NJ S3006

Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.

NJ A2281

Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.

NJ SB3103

MEDICAID-SICKLE CELL DISEASE

NJ HB5255

MEDICAID-SICKLE CELL DISEASE

NJ SB294

Enacting the Kansas medical cannabis act to authorize the cultivation, processing, distribution, sale and use of medical cannabis and medical cannabis products.

Similar Bills

No similar bills found.